“…Since EGBS is an internal fistula method, the tube can be indwelling for a long period of time without impairing a patient’s quality of life; in fact, long-term placement can be useful in preventing cholecystitis recurrence in patients with end-stage liver disease [ 10 , 11 , 12 ] and poor surgical candidates [ 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ] ( Figure 1 ). Based on research surrounding biliary stent placement for malignant or benign biliary strictures, it is unlikely that the stent will remain patent for years [ 27 , 28 ]. However, it appears that the stent not only facilitates bile drainage but also prevents gallstone impaction, thereby preventing recurrent cholecystitis.…”